Tomofumi Takaya - Concepedia

Author

Tomofumi Takaya

Also Known As

Motoaki Higuchi, T T Takaya, T TAKAYA, T Takaya, T. TAKAYA, T. Takaya, TOMOFUMI TAKAYA, Taishi Miyata, Tomofumi Takaya, Toshiro Shinke

240

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Kobe University Hyogo Brain and Heart Center Saiseikai Nakatsu Hospital Hyogo Prefectural Awaji Medical Center Keio University

About

Tomofumi Takaya is an author at Kobe University specializing in cardiology, medicine, and medical imaging.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	12	631
2	Engineering	5	5	117
3	Health Sciences	4	4	110
4	Public Health	4	4	411
5	Anatomy	2	2	35

Tomofumi Takaya

Publications

Citations

H-Index

Page 1

	Year	Citations
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly, The Lancet ThrombosisDose-finding Phase 2Cardiovascular DiseasePharmacologyCardiovascular Pharmacology	2022	296
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Circulation	2022	142
Angiotensin II type 1 receptor blocker telmisartan suppresses superoxide production and reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice Tomofumi Takaya, Seinosuke Kawashima, Masakazu Shinohara, Atherosclerosis InflammationVascular DiseaseOxysterolCardiovascular DiseaseMedicine	2005	109
A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression Tomofumi Takaya, Ken‐ichi Hirata, Tomoya Yamashita, Arteriosclerosis Thrombosis and Vascular Biology	2007	95
Effect of Daily Glucose Fluctuation on Coronary Plaque Vulnerability in Patients Pre-Treated With Lipid-Lowering Therapy Masaru Kuroda, Toshiro Shinke, Kazuhiko Sakaguchi, JACC: Cardiovascular Interventions Metabolic SyndromeCardiovascular DiseaseHealth PolicyGlobal HealthLipid-lowering Therapy	2015	83
Possible mechanism of late lumen enlargement after treatment for de novo coronary lesions with drug-coated balloon Tetsuya Yamamoto, Takahiro Sawada, Kenzo Uzu, International Journal of Cardiology	2020	78
Local Overexpression of Toll-Like Receptors at the Vessel Wall Induces Atherosclerotic Lesion Formation Masakazu Shinohara, Ken‐ichi Hirata, Tomoya Yamashita, Arteriosclerosis Thrombosis and Vascular Biology	2007	64
Torsades de Pointes with QT prolongation related to donepezil use Tomofumi Takaya, Masashi Okamoto, Keiko Yodoi, Journal of Cardiology MedicinePhysiologyQt Prolongation	2009	61
The impact of in-stent neoatherosclerosis on long-term clinical outcomes: an observational study from the Kobe University Hospital optical coherence tomography registry Masaru Kuroda, Hiromasa Otake, Toshiro Shinke, EuroIntervention	2016	60
Plasma Tetrahydrobiopterin/Dihydrobiopterin Ratio A Possible Marker of Endothelial Dysfunction Masafumi Takeda, Tomoya Yamashita, Masakazu Shinohara, Circulation Journal	2009	56

Page 1